￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Avmapki and Faczynja combination description application guide and market status

2026-02-01 22:25:32

Check Details
Standard usage and usual dosage of neratinib/neratinib

2026-02-01 22:25:32

Check Details
Detailed introduction to the production countries of bedaquiline’s original drug

2026-02-01 22:25:32

Check Details
Which four groups of people are not suitable for taking dasatinib?

2026-02-01 22:25:32

Check Details
Can I take Anamorelin for a long time and what are the side effects?

2026-02-01 22:25:32

Check Details
Baricitinib shows long-term safety in severe alopecia areata: 4-year trial data

2026-02-01 22:25:32

Check Details
What are the precautions for combining Avmapki and Faczynja?

2026-02-01 22:25:32

Check Details
Analysis of the difference in efficacy between tucatinib/tucatinib and 8201

2026-02-01 22:25:32

Check Details
When will Apelvis-Piqray be officially launched in China?

2026-02-01 22:25:32

Check Details
What is the starting dose and adjustment method of fotantinib/fotantinib?

2026-02-01 22:25:32

Check Details
What are the specific functions and effects of lenvatinib/lenvatinib and what are their effects?

2026-02-01 22:25:32

Check Details
Is Fezonatant considered a top antibiotic and how is it positioned?

2026-02-01 22:25:32

Check Details
Category
相关知识